Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-25-191273
Filing Date
2025-08-28
Accepted
2025-08-28 16:30:37
Documents
11
Period of Report
2025-08-25
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d40349d8ka.htm   iXBRL 8-K/A 26806
2 EX-99.1 d40349dex991.htm EX-99.1 7952
  Complete submission text file 0001193125-25-191273.txt   168899

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cprx-20250825.xsd EX-101.SCH 44638
14 EXTRACTED XBRL INSTANCE DOCUMENT d40349d8ka_htm.xml XML 5129
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33057 | Film No.: 251273998
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)